真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白

Recombinant Plasminogen Activator, Urokinase Receptor (uPAR)

CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3

  • 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 產(chǎn)品包裝(模擬)
  • 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 產(chǎn)品包裝(模擬)
  • 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Figure . Gene Sequencing (extract)
  • RPA141Hu04.jpg Figure. SDS-PAGE
  • Certificate 通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA141Hu01 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA141Hu02 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA141Hu04 尿激酶型纖溶酶原激活因子受體(uPAR)活性蛋白 Cell?culture;?Activity?Assays.
RPA141Hu04 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA141Hu03 尿激酶型纖溶酶原激活因子受體(uPAR)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA141Hu04 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體 WB
PAA141Hu01 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體 WB; IHC; ICC; IP.
PAA141Hu02 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體 WB; IHC; ICC; IP.
PAA141Hu03 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體 WB; IHC; ICC; IP.
LAA141Hu71 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
LAA141Hu83 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
LAA141Hu81 尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
FAA141Hu81 抗尿激酶型纖溶酶原激活因子受體(uPAR)多克隆抗體(異硫氰酸熒光素標(biāo)記) FCM
MAA141Hu22 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體 WB; IHC; ICC; IP.
MAA141Hu21 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體 WB; IHC; ICC; IP.
LAA141Hu82 尿激酶型纖溶酶原激活因子受體(uPAR)單克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
SEA141Hu 尿激酶型纖溶酶原激活因子受體(uPAR)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA141Hu 尿激酶型纖溶酶原激活因子受體(uPAR)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
International Journal of Cancer Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice [Wiley: source]
Biomark Insights Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607]
Biomarker insights Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD) [PubMed: PMC3762604]
Am J Emerg Med Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis [PubMed: 26615223]
Archives of Clinical Infectious Diseases Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis [Archcid: 26346]
The American Journal of Emergency Medicine Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis [science:S0735675715009559]
Journal of Clinical and Experimental Hepatology Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD)?… [10.1016:j.jceh.2018.02.001]
Turkish journal of trauma & emergency surgery The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis [Pubmed: 31475329]
CELL TRANSPLANTATION Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction [33787356]
留言咨詢
永仁县| 济宁市| 敖汉旗| 常宁市| 仪陇县| 宣城市| 赤壁市| 广东省| 界首市| 金门县| 德令哈市| 延长县| 霍林郭勒市| 赫章县| 浦县| 巨野县| 建平县| 灵丘县| 三原县| 澄江县| 辽宁省| 柳江县| 皋兰县| 嘉善县| 汶上县| 从化市| 监利县| 化州市| 三亚市| 鹤庆县| 类乌齐县| 五台县| 梅河口市| 县级市| 刚察县| 清涧县| 济源市| 宽甸| 新野县| 乾安县| 永胜县|